Our reviews

The 'Full list' option in the menu below will give you an up-to-date list of published reviews, registered titles and published protocols coordinated and edited by Cochrane Childhood Cancer. 

Our Reviews

Full list:

By subtopic:

Prevention (0)
Diagnosis (3)
Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung and lymph node metastases in rhabdomyosarcoma (protocol stage)
Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for detecting metastases of Ewing sarcoma (protocol stage)
¹²³I-MIBG- and 18F-FDG-PET-imaging, two nuclear imaging methods for diagnosing neuroblastoma tumours
Treatment (22)
Anti-GD2 antibody-containing immunotherapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation
Antibody therapies for lymphoma in children
Chemotherapy for children with medulloblastoma
Cyclophosphamide compared to ifosfamide for the treatment of sarcoma in children and young adults
Different infusion durations for preventing platinum-induced hearing loss in children with cancer
Focal laser treatment in addition to chemotherapy for retinoblastoma
Focal laser treatment in addition to chemotherapy for retinoblastoma
High-dose chemotherapy and stem cell transplant compared to conventional therapy for children with high-risk neuroblastoma
High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first recurrence of Ewing sarcoma (protocol stage)
High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with metastatic Ewing sarcoma (protocol stage)
High-dose chemotherapy for children and young adults with metastatic rhabdomyosarcoma
Intracystic bleomycin for children with cystic craniopharyngiomas
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma
Methotrexate for high-grade osteosarcoma in children and young adults
Minimally invasive surgery compared to open surgery for the treatment of solid tumours located in the chest or the abdomen of children
PEG-asparaginase treatment for acute lymphoblastic leukaemia in children: a network meta-analysis (protocol stage)
Radiotherapy for diffuse brainstem glioma in children and young adults
Rapid COJEC versus standard induction therapies for high-risk neuroblastoma
Retinoic acid after intensive chemotherapy and bone marrow transplantation in people with high-risk neuroblastoma
The role of interleukin-2 as maintenance therapy in children and adults with acute myeloid leukaemia in first complete remission
The role of interleukin-2 as maintenance therapy in children and adults with acute myeloid leukaemia in first complete remission
Treatment with or without anthracycline chemotherapy for childhood cancer
Supportive care: therapy-related side effects during treatment (24)
Catheter lock treatments for catheter-related infections in children with cancer
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
Different dosage schedules for reducing damage to the heart in people with cancer receiving anthracycline chemotherapy
Different dosage schedules for reducing damage to the heart in people with cancer receiving anthracycline chemotherapy
Different infusion durations for preventing platinum-induced hearing loss in children with cancer
Drugs to prevent heart damage in cancer patients receiving anthracyclines
Drugs to prevent heart damage in cancer patients receiving anthracyclines
Drugs to prevent nausea and vomiting in children and young people undergoing chemotherapy
Extracorporeal photopheresis for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients
Extracorporeal photopheresis treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients
Influenza vaccination in children being treated with chemotherapy for cancer
Interventions to prevent central venous catheter-related infections in children with cancer
Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia
Medicines to prevent hearing loss in children receiving platinum chemotherapy for cancer
Nutritional support in children and young people with cancer undergoing chemotherapy
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer
Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer (protocol stage)
Prevention of thrombosis in children with cancer and tunnelled CVCs
Suppression of the stress system in children who received synthetic stress hormones for acute lymphoblastic leukaemia
Thyroid dysfunction during treatment with systemic antineoplastic therapy for childhood cancer (protocol stage)
Treatment for cardiac problems caused by anthracycline chemotherapy for childhood cancer
Urate oxidase for the prevention and treatment of complications from massive lysis (breakdown) of tumour cells in children with cancer
Very early discharge versus early discharge versus non-early discharge in children with cancer and fever during neutropenia
Psychosocial care (1)
Ways of helping children with cancer to take part in decisions about their health care
Palliative and terminal care (0)
Nursing care (0)
Late effects: therapy-related side effects after treatment (14)
Adverse effects on the liver after treatment for childhood cancer
Anti-GD2 antibody-containing immunotherapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
Different dosage schedules for reducing damage to the heart in people with cancer receiving anthracycline chemotherapy
Drugs to prevent heart damage in cancer patients receiving anthracyclines
Early and late adverse effects on the kidney after treatment for childhood cancer
Extracorporeal photopheresis treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients
Hearing loss after treatment including platinum analogues for childhood cancer
Nutritional interventions for survivors of childhood cancer
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer
Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer (protocol stage)
Severe fatigue after treatment for childhood cancer
Suppression of the stress system in children who received synthetic stress hormones for acute lymphoblastic leukaemia
Treatment for cardiac problems caused by anthracycline chemotherapy for childhood cancer